Literature DB >> 12185398

A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions.

Andrea Zangara1, R J R Blair, H Valerie Curran.   

Abstract

RATIONALE: Accumulating evidence from neuropsychological and neuroimaging research suggests that facial expressions are processed by at least partially separable neurocognitive systems. Recent evidence implies that the processing of different facial expressions may also be dissociable pharmacologically by GABAergic and noradrenergic compounds, although no study has directly compared the two types of drugs.
OBJECTIVE: The present study therefore directly compared the effects of a benzodiazepine with those of a beta-adrenergic blocker on the ability to recognise emotional expressions.
METHODS: A double-blind, independent group design was used with 45 volunteers to compare the effects of diazepam (15 mg) and metoprolol (50 mg) with matched placebo. Participants were presented with morphed facial expression stimuli and asked to identify which of the six basic emotions (sadness, happiness, anger, disgust, fear and surprise) were portrayed. Control measures of mood, pulse rate and word recall were also taken.
RESULTS: Diazepam selectively impaired participants' ability to recognise expressions of both anger and fear but not other emotional expressions. Errors were mainly mistaking fear for surprise and disgust for anger. Metoprolol did not significantly affect facial expression recognition.
CONCLUSIONS: These findings are interpreted as providing further support for the suggestion that there are dissociable systems responsible for processing emotional expressions. The results may have implications for understanding why 'paradoxical' aggression is sometimes elicited by benzodiazepines and for extending our psychological understanding of the anxiolytic effects of these drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185398     DOI: 10.1007/s00213-002-1120-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

Review 1.  Facial expressions, their communicatory functions and neuro-cognitive substrates.

Authors:  R J R Blair
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-03-29       Impact factor: 6.237

2.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

3.  Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.

Authors:  Sunjeev K Kamboj; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-09-19       Impact factor: 4.530

Review 4.  Effects of benzodiazepines administration on identification of facial expressions of emotion: a meta-analysis.

Authors:  Helena Garcez; Carina Fernandes; Fernando Barbosa; Mariana R Pereira; Celeste Silveira; João Marques-Teixeira; Ana R Gonçalves
Journal:  Psychopharmacology (Berl)       Date:  2019-11-18       Impact factor: 4.530

5.  Naltrexone alters the processing of social and emotional stimuli in healthy adults.

Authors:  Margaret C Wardle; Anya K Bershad; Harriet de Wit
Journal:  Soc Neurosci       Date:  2016-01-22       Impact factor: 2.083

6.  Effects of diazepam on facial emotion recognition.

Authors:  Nick J Coupland; Anita J Singh; Ryan A Sustrik; Patricia Ting; R Blair
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

7.  Early effects of mirtazapine on emotional processing.

Authors:  D Arnone; J Horder; P J Cowen; C J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2008-11-25       Impact factor: 4.530

8.  Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.

Authors:  S K Kamboj; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

Review 9.  CNTRICS final task selection: social cognitive and affective neuroscience-based measures.

Authors:  Cameron S Carter; Deanna M Barch; Ruben Gur; Raquel Gur; Amy Pinkham; Kevin Ochsner
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

Review 10.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.